Data as of Jan 23
| -0.37 / -1.02%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 41.00, with a high estimate of 42.00 and a low estimate of 30.00. The median estimate represents a +13.64% increase from the last price of 36.08.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.